[1]
|
Nakamura E,Isobe H.Functioanlized fullerenes in water.The first 10 years of their chemistry,biology,and nanoscience.Acc Chem Res,2003,36(11):807-811. |
[2]
|
Stephen RW.Biological aspects of fullerenes.In:Karl MK.Rodney SR.Fullerenes:chemistry,physics and technology.New York:John Wiley Sons,2000.437-465. |
[3]
|
Tabata Y,Murakami Y,Ikada Y.Photodynamic effect of polyethylene glycol modified fullerene on tumor.Jpn J Cancer Res,1997,88(11):1108-1116. |
[4]
|
Qingnuan L,Yan X,Xiaodong Z,et al.Preparation of (99m)Tc-C(60)(OH)(x) and its biodistribution studies.Nucl Med Biol,2002,29(6):707-710. |
[5]
|
Simon HF,Dianne LD,Rint PS,et al.Inhibition of the HIV-1 Protease by fullerene derivatives:model building studies and experimental verification.J Am Chem Soc,1993,115:6506-6509. |
[6]
|
David IS,Stephen RW.Raymond FS.Anti-human immunodeficiency virus activity and cytotoxicity of derivatized buckminsterfullerenes.Bioorg Med Chem Let,1996,6(11):1253-1256. |
[7]
|
Sijbesma R,Srdanov G,Wudl F,et al.Synthesis of a fullerene derivative for the inhibition of HIV enzymes.J Am Chem Soc,1993,115:6510-6512. |
[8]
|
Rajagopalan P,Wudl F,Schinazi RF,et al.Pharmacokinetics of a water-soluble fullerene in rats.Antimicrob Agents Chemother,1996,40(10):2262-2265 |
[9]
|
Zhu Z,Schuster DI,Tuckerman ME.Molecular dynamics study of the connection between flap closing and binding of fullerene-based inhibitors of the HIV-1 protease.Biochemistry,2003,42(5):1326-1333. |
[10]
|
Marchesan S,Da Ros T,Spalluto G,et al.Anti-HIV properties of cationic fullerene derivatives.Bioorg Med Chem Lett,2005,15(15):3615-3618. |
[11]
|
Tatiana DR,Ester V,Giampiero S,et al.Design,synthesis and biological properties of fulleropyrrolidine derivatives as potential DNA photoprobes.J Supramol Chem,2002,2(1,3):327-334. |
[12]
|
Yu L,Yan-Li Zh,Yong Ch,et al.A Water-soluble β-cycodextrin derivative possessing a fullerene tether as an efficient photodriven DNA-cleavage reagent.Tetra Lett,2005,46:2507-2511. |
[13]
|
Arimondo PB,Moreau P,Boutorine A,et al.Recognition and cleavage of DNA by rebeccamycin-or benzopyridoquinoxaline conjugated of triple helix-forming oligonucleotides.Bioorg Med Chem,2000,8(4); 777-784. |
[14]
|
Imahori H,Fukuzumi S.Porphyrin and fullerene-based photovoltaic devices.Advanced Functional Materials,2004,14(6):525-536. |
[15]
|
Krusic PJ,Wasscerman E,Keizer PN,et al.Radical reactions of C60.Science,1991,254(5035):1183-1185. |
[16]
|
Dugan LL,Turetsky DM,Du C,et al.Carboxyfullerenes as neuroprotective agents.Proc Natl Acad Sci USA,1997,94(17):9434-9439. |
[17]
|
Corona-Morales AA,Castell A,Escobar A,et al.Fullerene and ascorbic acid protect cultured chromaffin cells against levodopa toxicity.J Neurosci Res,2003,71(1):121-126. |
[18]
|
Shuying Liu,Shuqing Sun,Recent progress in the studies of endohedreal metallofullerenes.J Organometal Chem,2000,599:75-86 |
[19]
|
Wharton T,Wilson LJ.Highly-iodinated fullerene as a contrast agent for X-ray imaging.Bioorg Med Chem,2002,10(11):3545-3554. |
[20]
|
Bolskar RD,Benedetto AF,Husebo LO,et al.First soluble M@C60 derivatives provide enhanced access to metallofullerenes and permit in vivo evaluation of Gd@C60[C(COOH)2]10 as a MRI contrast agent.J Am Chem Soc,2003,125(18):5471-5478. |
[21]
|
Toth E,Bolskar RD,Borel A,et al.Water-soluble gadofullerenes:toward high-relaxivity,pH-responsive MRI contrast agents.J Am Chem Soc,2005,127(2):799-805. |
[22]
|
Xenogiannopoulou E,Couris S,Koudoumas E,et al.Nonlinear optical response of some isomerically pure higher fullerenes and their corresponding endohedral metallofullerene derivatives:C82-C2v,Dy@C82(Ⅰ),Dy2@C82(Ⅰ),C92-C2 and Er2@C92(Ⅳ).Chem Phy Lette,2004,394(1):14-18. |
[23]
|
Watanabe S,Ishioka NS,Shimomura H,et al.Synthesis of hydrophilic endohedral 133Xe-fullerenol with high yield.JAERI(Japan Atomic Energy Research Institute) Review,2004,25(11):248-249. |
[24]
|
Cagle DW,Kennel S J,Mirzadeh S,et al.In vivo studies of fullerenebased materials using endohedral metallofullerene radiotracers.Proc Natl Acad Sci USA,1999,96(9):5182-5187. |